retatrutide phase 2 results 2024 2025 press release π may be redefining obesity treatment. New data from TRIUMPH-1 Trial showed: π₯ ~28% average weight loss over 80 weeks π₯ >30% weight loss in nearly half of participant #ObesityMedicine #Retatrutide #GLP1 #CardioMetabolic Retatrutide 2026: 28.3% Weight Loss
Pay in 4 interest-free payments of $6.96 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 4 - Aug 9



00967-0/asset/1cda1e69-507e-47d1-ad73-620bcd1cbb66/main.assets/gr2_lrg.jpg)



















